# Trade Mark Journal No.2026/024 12 June 2026

## UK00004394565 29 May 2026 (5,10,35,42,44)

HISTOPREDICT

International priority date claimed: 10 February 2026 (United States of America) (99645280)

Class 5
  Diagnostic preparations for medical purposes; Diagnostic reagents for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, detecting cancer; Diagnostic kits comprising diagnostic agents, preparations and substances for medical use.
Class 10
  Medical diagnostic apparatus for detecting cancer; Medical diagnostic apparatus for testing for cancer; Blood testing apparatus, namely, blood collecting tubes.
Class 35
  Business consulting services in the field of healthcare; Electronic data collection and data submission services for business purposes in the fields of medicine and healthcare; Business services provided to the healthcare industry, namely, the collection, reporting, and analysis of healthcare quality data for business purposes.
Class 42
  Providing medical and scientific research information; Medical and scientific research in the field of genetic testing; Genetic testing for scientific research purposes; Providing a website featuring educational information in the field of clinical research; Providing information about medical research in the field of genetic testing and oncology; Software as a service (SAAS) services featuring software for collecting, verifying, storing, analyzing, and transmitting information and reports concerning genetics, genetic mutations, genetic test results, diagnoses and treatments; providing a website featuring medical information; providing a website featuring information in the field of the diagnosis and treatment of cancer.
Class 44
  Genetic testing for medical purposes; Genetic counseling; Medical laboratory analysis services relating to the treatment of persons; Providing information about genetic testing for medical purposes; Providing health information in the field of genetic testing and oncology; Genetic testing for cancer risk for medical purposes; Medical analysis services for the diagnosis of cancer; Medical analysis for the diagnosis and treatment of persons; Providing information in the field of the diagnosis and treatment of cancer via a website.

Natera, Inc.

Representative: J A Kemp LLP